We are live on ! Find out more
VF

Virtu Financial Portfolio holdings

AUM $2.41B
1-Year Est. Return 48.35%
This Fund
S&P 500
This Quarter Est. Return
+3.1%
1 Year Est. Return
+48.35%
3 Year Est. Return
+116.81%
5 Year Est. Return
+139.6%
10 Year Est. Return
AUM
$1.67B
AUM Growth
-$192M
Cap. Flow
-$208M
Cap. Flow %
-12.46%
Top 10 Hldgs %
16.23%
Holding
2,892
New
1,004
Increased
436
Reduced
473
Closed
952

Sector Composition

Rank Sector Weight
1 Financials 9.89%
2 Technology 6.14%
3 Consumer Discretionary 5.43%
4 Healthcare 4.72%
5 Industrials 4.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROX
1826
DELISTED
Castle Brands, Inc.
ROX
$30K ﹤0.01%
25,186
-52,987
-68% -$65.8K
OMED
1827
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$30K ﹤0.01%
+12,843
New +$37.4K
CHCI icon
1828
Comstock Holding Companies
CHCI
$153M
$28K ﹤0.01%
+10,612
New +$28.3K
PWCM
1829
PowerCompute, Inc. Common Stock
PWCM
$1.41M
$28K ﹤0.01%
8
+6
+300% +$27.2K
SPI
1830
DELISTED
SPI Energy Co., Ltd. Ordinary Shares
SPI
$28K ﹤0.01%
+7,155
New +$30.6K
SBSW icon
1831
Sibanye-Stillwater
SBSW
$7.51B
$27K ﹤0.01%
11,230
-20,943
-65% -$64.5K
SINT icon
1832
SiNtx Technologies
SINT
$11.3M
0
CHKR
1833
DELISTED
CHESAPEAKE GRANITE WASH TRUST
CHKR
$27K ﹤0.01%
16,781
-53,049
-76% -$81.8K
CRVO icon
1834
CervoMed
CRVO
$41.8M
$25K ﹤0.01%
48
+25
+109% +$14.8K
HOV icon
1835
Hovnanian Enterprises
HOV
$805M
$25K ﹤0.01%
+601
New +$28.3K
AVGR
1836
DELISTED
Avinger, Inc. Common Stock
AVGR
$25K ﹤0.01%
+5
New +$22K
NBSE
1837
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$25K ﹤0.01%
318
+73
+30% +$6.37K
BIOC
1838
DELISTED
Biocept, Inc.
BIOC
$25K ﹤0.01%
+14
New +$28.3K
PRKR
1839
DELISTED
Parkervision Inc
PRKR
$25K ﹤0.01%
+37,867
New +$26.7K
BBOX
1840
DELISTED
Black Box Corp
BBOX
$25K ﹤0.01%
12,526
-11,388
-48% -$25K
CREG
1841
DELISTED
Smart Powerr
CREG
$24K ﹤0.01%
16
+3
+23% +$5K
NBEV
1842
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$24K ﹤0.01%
13,055
-69,493
-84% -$131K
ALO
1843
DELISTED
Alio Gold Inc
ALO
$24K ﹤0.01%
16,687
-14,589
-47% -$25.9K
OTIV
1844
DELISTED
OTI On Track Innovations Ltd
OTIV
$24K ﹤0.01%
+20,808
New +$23.8K
PALI icon
1845
Palisade Bio
PALI
$373M
0
PHIO icon
1846
Phio Pharmaceuticals
PHIO
$12.7M
$23K ﹤0.01%
2
-2
-50% -$29.6K
GRCE
1847
Grace Therapeutics
GRCE
$44.6M
$23K ﹤0.01%
856
+275
+47% +$10.6K
SCU
1848
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$23K ﹤0.01%
1,215
-4,361
-78% -$92.9K
GURE
1849
Gulf Resources
GURE
$4.91M
$22K ﹤0.01%
+322
New +$22.8K
IGC icon
1850
IGC Pharma
IGC
$29.3M
$22K ﹤0.01%
44,012
-21,346
-33% -$12.3K

Similar funds

Virtu Financial's Q2 2018 Portfolio in Review

As of Q2 2018, Virtu Financial held 2,892 positions worth $1.67B, down 10% from $1.86B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Virtu Financial withdrew a net $208M in Q2 2018, closing 952 positions and reducing 473 holdings. Its most notable exit was iShares US Real Estate ETF, an estimated $20.6M position sold in full.

By sector, the portfolio is most concentrated in Financials at 9.9% of assets, up from 4.5% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Virtu Financial opened a new position in Berkshire Hathaway Class B worth $86M.

  • Virtu Financial's largest Q2 2018 buy was Berkshire Hathaway Class B: 460,798 shares worth $86M.
  • Virtu Financial added most to iShares MSCI Canada ETF in Q2 2018, an estimated $13.3M increase.
  • Virtu Financial's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $205M.
  • Virtu Financial fully exited iShares US Real Estate ETF in Q2 2018, selling an estimated $20.6M.
  • Virtu Financial's ten largest holdings make up 16% of its $1.67B portfolio in Q2 2018.
  • Virtu Financial opened 1,004 new positions and closed 952 in Q2 2018.
  • Virtu Financial's portfolio value fell 10% quarter-over-quarter to $1.67B.

Based on Virtu Financial's 13F filing for Q2 2018, filed 30 Jul 2018.